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for Isolated LV Noncompaction in CMRR. Brandon Stacey, MD, MS,* Mousumi M. Andersen, MD,* Mitchell St. Clair, MD,*
W. Gregory Hundley, MD,*y Vinay Thohan, MD*
Winston-Salem, North CarolinaOBJECTIVES This study used cardiac magnetic resonance (CMR) to compare standard criteria for left
ventricular noncompaction (LVNC).
BACKGROUND LVNC as a distinct cardiomyopathy is supported by a growing number of publica-
tions. Echocardiographic and CMR criteria have been established to diagnosis LVNC but have led to con-
cerns of diagnostic accuracy.
METHODS Trabeculation/possible LVNC by CMR was retrospectively observed in 122 consecutive
cases. We compared the standard end-systolic noncompacted-to-compacted ratio (ESNCCR), end-
diastolic noncompacted:compacted ratio (EDNCCR), and trabecular mass-to-total mass ratio (TMTMR)
along with deaths, embolic events, congestive heart failure (CHF) readmissions, ventricular arrhythmias,
myocardial thickening (MT), left ventricular ejection fraction (LVEF), 3-dimensional sphericity index (3DSi),
and left ventricular end-diastolic volume index. Adjusting for age, race, sex, body surface area, diabetes
mellitus, hypertension, hyperlipidemia, coronary artery disease, and CHF, logistic regression was used to
compare combined events (death, CHF readmission, embolism, ventricular arrhythmia) between ESNCCR,
EDNCCR, and TMTMR. Adjusting for same covariates except CHF, logistic regression was used to compare
the odds of CHF for those who met criteria and those who did not. Using analysis of covariance, adjusted
means for LVEF, MT, 3DSi, and left ventricular end-diastolic volume index were generated.
RESULTS ES criteria had a higher odds ratio (8.6; 95% conﬁdence interval [CI]: 2.5 to 33) for combined
events than ED criteria (1.8; 95% CI: 0.6 to 5.8) or TMTMR criteria (3.14; 95% CI: 1.09 to 10.2). The odds
ratio of CHF for those who met ESNCCR criteria was 29.4 (95% CI: 6.6 to 125), but the odds ratio of
CHF for those who met EDNCCR criteria was 3.3 (95% CI: 1.1 to 9.2). After adjustment, those who met
criteria for noncompaction by ESNCCR had a lower LVEF and less MT than those who did not (p ¼
0.01 and p ¼ 0.003, respectively), but there was no difference between those who met criteria for
EDNCCR or the TMTMR criteria and those who did not.
CONCLUSIONS ES measures of LVNC have stronger associations with events, CHF, and systolic
dysfunction than other measures. (J Am Coll Cardiol Img 2013;6:931–40) ª 2013 by the American
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3DSi = 3-dimensional sphe
index
BSA = body surface area
CHF = congestive heart fai
CMR = cardiac magnetic
resonance
ED = end-diastolic
EDNCCR = end-diastolic
noncompacted-to-compact
ratio
ES = end-systolic
ESNCCR = end-systolic
noncompacted-to-compact
ratio
LV = left ventricular
LVEDVi = left ventricular e
diastolic volume index
LVEF = left ventricular ejec
fraction
LVNC = left ventricular
noncompaction
MT = myocardial thickenin
NC = noncompaction
TMTMR = trabecular mass
total mass ratio
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932nterest in left ventricular noncompaction (LVNC)
as a distinct form of cardiomyopathy has increased
over the past decade after several publications
established a congenital/genetic abnormality of
myocardial compaction (1,2). Reliable imaging
criteria are central to deﬁning a speciﬁc phenotype of
LVNC. As imaging techniques improve, spatial
resolution of the endocardial borders, differentiation
of noncompacted from compacted myocardium, and
distinction of trabeculation from normal anatomicSee page 941
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-to-variants has become easier (3), and, there-
fore, identiﬁcation of LVNC continues to
change (4). This evolution of imaging
modalities has led to some concerns that
LVNC may be overdiagnosed (5,6).
Complicating this situation, LVNC car-
diomyopathy shares many of the clinical
features associated with other forms of
dilated cardiomyopathy (7). Therefore, an
ideal imaging modality would both differ-
entiate myopathic noncompaction (NC)
from normal variants as well as other
pathological cardiomyopathies, thus estab-
lishing a unique imaging phenotype.
In 2000, Oechslin et al. (2) published the
seminal paper deﬁning the echocardio-
graphic criteria for the diagnosis of LVNC
cardiomyopathy, the hallmark of which was
tomeasure the end-systolic noncompacted-
to-compacted ratio (ESNCCR) in
myocardium. In 2005, these criteria were
validated using a unique population (8).
During this same time interval, the appli-
cation of cardiac magnetic resonance
(CMR) as a diagnostic modality led to
several publications redeﬁning LVNC (9).
Initial attempts to measure end-systole byCMR were limited due to image quality, temporal
resolution, and image sequences (10). As such,
Petersen et al. (11) presentedCMR criteria of LVNC
based on the end-diastolic noncompacted-to-
compacted ratio (EDNCCR). The difference in
end-diastolic (ED) and end-systolic (ES) criteria has
led to confusion regarding the true phenotypic
expression of LVNC, and, therefore, current trends
with CMR criteria (EDNCCR) may lead to greater
sensitivity with limited speciﬁcity. More recently,
some investigators have also introduced a trabecular
mass–to–total mass ratio (TMTMR) to diagnose
individuals with LVNC (12).We postulate that CMR measures of ESNCCR
are feasible and, compared with EDNCCR and
TMTMR, may improve the clinical recognition of
LVNC from other forms of cardiomyopathy.
METHODS
Study population. After obtaining institutional re-
view board approval, we retrospectively queried the
clinical CMR database at Wake Forest Baptist
Hospital for descriptions of trabeculations or NC. A
total of 4,762 patients had CMR studies performed
between January 2007 and April 2011, of which 122
original patients (2.5%) had reports that included
descriptions of trabeculations or noncompaction,
and our study population comprised these clinical
cases. Clinical and demographic data were extracted
from the electronic medical records.
Cardiac magnetic resonance. Images were acquired
on a 1.5-T unit (Avanto, Siemens Medical Solu-
tions, Erlangen, Germany) using steady-state free
precession. Cine images (echo time/repetition time,
1.5/3.0 ms, respectively; ﬂip angle, 60) were ac-
quired in 3 long-axis views (i.e., 2-, 3-, and
4-chamber views), planned on short-axis pilots at 60
angles to each other. Multislice cine views were also
acquired in the short-axis plane from the base to the
apex to visualize all 17 segments according to the
American Heart Association recommendation (13).
CMR NC measurements. Using short-axis cine im-
ages, the noncompacted and compacted layers were
visually identiﬁed, and the papillary muscles were
speciﬁcally excluded from measurement. The region
with the largest noncompacted-to-compacted ratio
was measured in end-diastole (Fig. 1) and end-
systole (Fig. 1) using WebPAX (Heart Imaging
Technologies, LLC, Durham, North Carolina).
Apical short-axis views 16 to 24 mm from the true
apical slice were used for all measurements due to the
risk of overestimating the noncompacted-to-
compacted ratio in more apical slices. Short-axis
views were used to prevent identifying a papillary
muscle or its attachments as isolated trabeculation on
long-axis views. Longitudinal views were only used
to assess involvement in the true apical segment, but
no measurements were recorded. In accord with
previously published standards, individuals were
categorized as ES NC if the ESNCCR was$2, and
individuals were categorized as ED NC if the
EDNCCR was $2.3 (2,11). The number of
segments with associated trabeculation was also
measured.
Trabecular mass-to-total mass ratio. The trabecular
mass and its ratio was calculated based on the
Figure 1. Still Cardiac Magnetic Resonance Images From End-Diastole and End-Systole With Demonstration of How
Measurements Were Taken
The yellow line measures the compacted layer; the red line measures the noncompacted layer. (Top) Images obtained from an asymp-
tomatic 40-year-old man who met end-diastolic criteria but not end-systolic criteria. (Bottom) Images obtained from a 35-year-old woman
with congestive heart failure who met both end-diastolic and end-systolic criteria.
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TMTMR, the trabecular border and papillary
muscles were measured at end-diastole. The papil-
lary muscles were included because it was difﬁcult to
distinguish between papillary muscle and trabecu-
lations in the more densely trabeculated left ven-
tricles. The trabeculated mass was calculated by
subtracting the nontrabeculated left ventricular (LV)
cavity volume from the LV end-diastole volume,
which contained the entire LV cavity contained by
the compacted myocardium. The trabecular volume
was multiplied by the speciﬁc gravity to calculate the
trabecular mass. Total LV mass was calculated by
subtracting the nontrabeculated LV cavity from the
LV epicardial volume and multiplying by the spe-
ciﬁc gravity. The trabeculated mass-to-total LV
mass ratio was calculated. The previous study
established 20% as a cutoff, but because papillarymuscles were included in the trabeculated mass, the
cutoff used for our analysis was 40%. Previous LV
mass studies estimated that papillary muscle inclu-
sion could increase the total LV mass by 10% (14).
Papillary muscle classiﬁcation system. Using the
mid-level short axis cine images at end-diastole, the
papillary muscles were identiﬁed. The papillary
muscles were grouped into 3 different categories
(Fig. 2): 0, no identiﬁable papillary muscle or small
muscular band contained within trabeculations; 1,
1 papillary muscle appears fully developed and in-
dependent of trabeculations, whereas the remaining
papillary muscle is either not identiﬁed or contained
within trabeculations; 2, both papillary muscles
appear fully developed and independent of sur-
rounding trabeculations.
CMR volume measurements. LV ED volume, ES
volume, and left ventricular ejection fraction
Figure 2. Cardiac Magnetic Resonance of the Different Papillary Muscle Groupings
From left to right, groups 0, 1, and 2.
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software (Argus version 4.02, Siemens Medical
Systems). ED and ES frames were deﬁned as the
frames in which the cavity sizes were largest and
smallest by retrospective image review (15–17). The
endocardial border was manually traced in the
selected image frames. The papillary muscles and
LV trabeculae were excluded from the endocardium
and included in the LV cavity volume (18). At the
base of the heart, slices were considered to be within
the left ventricle if the blood volume was surrounded
by $50% of ventricular myocardium (3).
Myocardial thickening (MT) was calculated by
the following equation from the compared layer
measurements obtained at the apex where the
noncompacted-to-compacted ratio was measured:
ED compacted layer thickness (mm)  ES com-
pacted layer thickness (mm)/ED compacted layer
thickness (mm).
The 3-dimensional sphericity index (3DSi) was
calculated by the following equation (19,20): ES
volume/[4/3  p  (D/2)3] and the left ventricular
end-diastolic volume index (LVEDVi) as EDV/
body surface area (BSA).
Clinical events. Congestive heart failure (CHF) was
deﬁned as having a clinical diagnosis of CHF by
medical record. Data were also gathered concerning
death, heart failure readmission, embolic events, and
ventricular arrhythmias, events previously described
as being associated with LV noncompaction (2). To
assess death, both the medical chart and the Social
Security Death Index were searched. To assess heart
failure readmission rates, the medical chart was
reviewed, and a readmission was counted if they had
been admitted for CHF after undergoing CMR to
identify the trabeculations. To assess embolic
events, the medical chart was reviewed for radiologic
reports, neurology evaluations, and other notationsfor any description of an embolic event. To assess
for ventricular arrhythmias, the medical chart was
reviewed for cardiology consultations and device
interrogations. Heart failure readmissions, death,
ventricular arrhythmias, and embolic events were
pooled for statistical power and represented a clin-
ical phenotype of LVNC cardiomyopathy.
Covariates. Diabetes was deﬁned as a participant
who had a diagnosis of diabetes orwas taking glucose-
regulating medication. Hypertension was deﬁned as
a diagnosis of hypertension. Given that many of
the medications used to treat CHF are also antihy-
pertensives, we could not use antihypertensive
medications as an indication of hypertension.
Hyperlipidemia was deﬁned as a diagnosis of hyper-
lipidemia or taking a lipid-lowering medication.
Coronary artery disease (CAD) was deﬁned as
documented obstructive coronary artery stenosis, a
history of percutaneous coronary intervention, or a
history of coronary artery bypass graft surgery.
Statistical analysis. All CMR baseline data were
presented as mean  SD. Nominal data were tested
using the chi-square test. Baseline variables were
compared between those who met criteria for ES
NC and those who did not and between those who
met criteria for ED NC and those who did not.
Categorical data were analyzed using logistic
regression. The dependent variables used were base-
line CHF and combined clinical events. Covariates
used for adjustment included age, race, sex, BSA,
diabetes mellitus, hypertension, hyperlipidemia,
CHF, and CAD. When CHF was the dependent
variable, the logistic regression model was not
adjusted for CHF.
Continuous data were analyzed using Pearson
correlation and analysis of covariance to generate
adjusted means. Separate models were used to
compare the effects of ED NC and ES NC.
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LVEDVi. Analysis adjusted for age, race, sex, BSA,
diabetes mellitus, hypertension, hyperlipidemia,
CAD, and CHF. Of note, in the analysis involving
LVEDVi, there was no adjustment for BSA. A p
value <0.05 was considered statistically signiﬁcant.
Correlations were also used to describe unadjusted
linear relationships. All statistical analyses were
performed using SAS software version 9.1 (SAS
Institute, Inc., Cary, North Carolina).
To describe the relationship between papillary
muscle structure and different measures of NC, the
chi-square test was used to compare the overall
signiﬁcance of the association of the papillary
muscle groups with the different diagnostic criteria
for NC.
To assess interobserver and intraobserver agree-
ment, a subset of cases were randomly selected and
interpreted by a second reader blinded to all infor-
mation (n ¼ 20). Interobserver and intraobserver
agreement was assessed with Spearman’s correlationTable 1. Baseline Characteristics: Overall Study Population With Br
B
Overall
(N [ 122)
End-Systolic
Noncompacted-
Compacted Rat
<2.0 (n [ 91) ‡2.0
Age, yrs 57  17.5 57.8  16.9 54.
African American 31 31
Female 50 50
BSA, m2 2.0  0.4 2.0  0.3 1.
Diabetes 21 17
Hypertension 56 60
Hyperlipidemia 35 34
CHF 36 20
CAD 15.7 13
Hospitalizations 2  3.4 1.6  2.5 3
Death 6 4
Embolic event 10 5
Heart failure readmission 14 6
Ventricular arrhythmia 6 1
BNP, pg/ml 667  795 450  744 923
LVEF 44  16 48.5  14.6 30
LVEDVi, ml/m2 87  37 78  30 12
3DSi 0.36  0.1 0.33  0.1 0.46
Noncompacted segments 6.2  2.7 5.4  2.3 8.0
MT 36  25 46.8  24 5
Values are mean  SD or %. *Statistical difference with p < 0.05 in comparison be
BNP ¼ B-type natriuretic peptide; BSA ¼ body surface area; CAD ¼ coronary artery
thickening; 3DSi ¼ 3-dimensional sphericity index.analyzing the ED and ES thickness of the com-
pacted and noncompacted layers. Spearman’s cor-
relation was also used to assess intraobserver and
interobserver agreement regarding the TMTMR.
Table analysis was used to assess interobserver and
intraobserver agreement for the papillary muscle
classiﬁcation system. Agreement between ED and
ES NC measures was also performed with table
analysis and the kappa statistic.
RESULTS
Baseline characteristics are presented in Table 1.
The overall population is older compared with
previous investigations for LVNC (age, 57 
17 years), predominantly white (69%) with approxi-
mately one-third havingCHF and one-fourth having
CAD. The LVEF is 44  16% and LVEDVi is
87  37 ml/m2. We analyzed the CMR data for
relevant trends after separating the overall population
into diagnostic criteria of ESNCCR, EDNCCR,eakdown by Those Who Met End-Diastolic or End-Systolic Criteria
aseline Characteristics
to-
io
End-Diastolic
Noncompacted-to-
Compacted Ratio
Trabecular Mass-to-Total
Mass Ratio
(n [ 31) <2.3 (n [ 88) ‡2.3 (n [ 34) <40% (n [ 52) ‡40% (n [ 70)
6  19.5 59.7  15 49.9  20* 55.4  17 60.4  16
32 30 35 40 25
52 45 62 49 52
9  0.2 2.0  0.3 1.9  0.2 2.0  0.27 1.9  0.24
32 18 27 17 24
45 57 52 66 29
39 35 36 32 39
80* 28 57* 29 42
24 13 24 12 18
.1  5* 1.7  3.1 2.6  4.0 1.9 2.1
10 7 3 4 7.6
23* 9 11 3.9 14.5*
38* 8 2* 10 16.7*
20* 2 14 2 8.7
 793* 569  891 817  613 675  890 662  749
 11.7* 46  15 37  16.8* 43.8  15 43.7  15
0  39* 78  30 111  43* 79.4  31.5 94  37.6*
 0.13* 0.35  0.12 0.41  0.15* 0.33  0.10 0.39  0.14*
 2.5* 5.7  2.6 7.4  2.4* 5.5  2.6 6.7  2.7
.6  30* 35.2  18 39.2  30 38.4  41.5 32.9  37.8
tween those who met the respective criteria and those who did not.
disease; CHF ¼ congestive heart failure; LVEDVi ¼ left ventricular end-diastolic volume index; MT ¼myocardial
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936and TMTMR. A clinical diagnosis of CHF was
statistically more common among those who met the
ESNCCR (80% vs. 20%) and EDNCCR (57% vs.
28%) criteria. There were slightly more who had
CHF in those whomet the TMTMR (42% vs. 29%),
but it was not statistically signiﬁcant. The individuals
who met either ESNCCR or EDNCCR criteria
had a lower LVEF than those who did not (48.5 
14.6 vs. 30  11.7 and 46  15 vs. 37  16.8,
ESNCCR and EDNCCR, respectively). However,
those who met criteria with the TMTMR did not
have a difference in LVEF compared with those who
did not meet criteria (43.7  15 vs. 43.8  15).
ESNCCR, EDNCCR, and TMTMR were associ-
ated with increased LVEDVi and 3DSi. Only in-
dividuals who fulﬁlled the ESNCCR criteria had
statistically signiﬁcant differences in MT parameters
(5.6  11.6% vs. 46.8  24%). The MT pa-
rameters in both subgroups evaluated by EDNCCR
criteria were not different (39.2 25% vs.35.2
18%), nor were they different for the TMTMR
criteria (32.9 37.8 vs.38.4 41.5). WithMT,
both groups for TMTMR and EDNCCR were
comparable to the subgroup of patients who did not
meet the ESNCCR criteria (46.8  24%). AY = 2.34 – 0.0098*EF
p = 0.0098
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Figure 3. Scatterplots of Relationships Between End-Diastolic and E
and Myocardial Thickening
Simple unadjusted linear regression lines applied to demonstrate relation
visual comparison with MRI ejection fraction. MT ¼ myocardial thickenscatterplot analysis with simple linear regression lines
depicts the relationship between ESNCCR and
EDNCCR with LVEF and MT (Fig. 3). Further-
more after analyzing both groups, ESNCCR
continued to outperform EDNCCR and TMTMR
with regard to LVEF, MT, and 3DSi.
LV size and function. The analysis of covariance
models for ESNCCR, EDNCCR, and TMTMR
presented in Table 2 is adjusted for age, race, sex,
BSA, tobacco use, diabetes mellitus, hypertension,
hyperlipidemia, CAD, and CHF. Those who met
criteria for ESNCCR demonstrated statistically
lower LVEF (31.8  6% vs. 40.4  8.8%), whereas
those who met criteria for EDNCCR or TMTMR
did not. Of note, not adjusting for CHF with 3DSi
demonstrated signiﬁcant results, which suggests
that sphericity may be in the causal pathway be-
tween ESNCCR and CHF.
CHF and combined clinical events. After logistic
regression analysis of the data based on the 2 criteria
used, subjects who met ESNCCR criteria had
greatest odds ratio for the presence of clinical heart
failure after adjustment for the covariates listed above
(odds ratio [OR]: 29.4, 95% conﬁdence interval
[CI]: 6.6 to 125) (Table 3). Logistic regression alsoY = 2.6 – 0.03*EF
p < 0.0001
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p < 0.0001
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nd-Systolic Measures of Noncompaction With Ejection Fraction
ship, if any. Myocardial thickening multiplied by "-" to allow for easier
ing.
Table 2. ANCOVA to Generate Adjusted Means With 95% Conﬁdence Intervals
Adjusted Means for EF, MT, LVEDVi, and 3DSi Compared Between Different Noncompaction Criteria
LVEF (%) p Value MT, % p Value
LVEDVi,
ml/m2 p Value
3DSi*
(Without CHF) p Value
3DSi*
(With CHF) p Value
ES NC:C ratio $2 31.8  6 0.01 9.4  16.2 0.003 116  14 0.008 0.47  0.05 <0.001 0.42  0.05 0.2
ES NC:C ratio <2 40.4  8.8 37.2  12 93  9 0.36  0.05 0.38  0.04
ED NC:C ratio $2.3 36.4  5.4 NS 37.3  12.3 0.07 116  12 <0.001 0.44  0.05 0.02 0.41  0.05 0.2
ED NC:C ratio <2.3 38.4  4.5 27.0  14.8 91  11 0.37  0.05 0.38  0.05
TrabM:TM ratio $40% 38.0  4.1 NS 25.9  11.6 NS 100.7  9.8 0.054 0.42  0.04 0.015 0.41  0.04 0.03
TrabM:TM ratio <40% 36.5  4.8 26.5 13.6 89.1  11.6 0.36  0.05 0.36  0.04
Adjusted for age, race, sex, body surface area, diabetes mellitus, hypertension, hyperlipidemia, coronary artery disease, and CHF. Without adjusting 3DSi for CHF, there is a signiﬁcant relationship,
which suggests that sphericity may be in the causal pathway between differing measures of noncompaction and CHF. *3DSi measured at end-systole.
ANCOVA ¼ analysis of covariance; ED ¼ end-diastolic; LVEF ¼ left ventricular ejection fraction; ES ¼ end-systolic; NC:C ¼ noncompacted-to-compacted; TrabM:TM ¼ trabeculated mass–to-total
mass; other abbreviations as in Table 1.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 9 , 2 0 1 3 Stacey et al.
S E P T E M B E R 2 0 1 3 : 9 3 1 – 4 0 CMR Criteria for LV Noncompaction
937demonstrated that ESNCCR had a higher OR (OR:
8.6; 95% CI: 2.5 to 33) for combined clinical events
than TMTMR (OR: 3.14; 95% CI: 1.09 to 10.4)
and EDNCCR (OR: 1.8; 95% CI: 0.6 to 5.8)
(Table 3). To determine which aspect of the ratio was
more signiﬁcant, the same logistic regression model
was performed with combined clinical events as the
dependent variable with separate models run for ED
noncompacted layer, ED compacted layer, ES non-
compacted layer, ES compacted layer, trabecular
mass, and total LV mass. The ES noncompacted
layer and the ES compacted layer had higher odds of
having clinical events (p ¼ 0.0008 and p ¼ 0.002,
respectively), and there was also higher odds for
increased trabecular mass (p¼ 0.02). However, there
were not higher odds for ED noncompacted layer,
ED compacted layer, or total LV mass. Using anal-
ysis of covariance, the adjusted mean of ES non-
compacted layer for those who had clinical events was
14.5  0.75 (95% CI) mm versus 9.9  0.6 mm
(p ¼ 0.0004), and the adjusted mean of the ES
compacted layer for those who had clinical events was
8  0.6 mm versus 10.2  0.4 mm (p ¼ 0.004).
Papillary muscle groups and noncompaction
criteria. In evaluating the relationship between theTable 3. Logistic Regression Analysis Used to Generate
ORs (CIs) for CHF and Combined Clinical Events Separately
ORs (CIs) for CHF and Clinical Events
Associated With Noncompaction
ES NC:C
Ratio ‡2.0
ED NC:C
Ratio ‡2.3
TrabM:TM
Ratio ‡40%
CHF 29.4 (6.6–125) 3.3 (1.13–9.2) 1.99 (0.82–5.0)
Combined events 8.6 (2.5–33) 1.8 (0.57–5.8) 3.14 (1.09–10.2)
Combined events included having at least one of the following: death, mul-
tiple heart failure hospitalizations, embolic events, or ventricular arrhythmias.
Adjusted for age, race, sex, BSA, tobacco use, diabetes mellitus, hypertension,
hyperlipidemia, CAD. Combined events also adjusted for CHF.
ORs ¼ odds ratios; other abbreviations as in Tables 1 and 2.papillary muscle groups and the different diagnostic
criteria, there was more abnormal papillary muscle
structure noted in thosewhomet criteria byESNCCR
and EDNCCR (p < 0.0001 for both comparisons).
The TMTMR had a more modest association with
the papillary muscle groups (p ¼ 0.017) (Table 4).
Agreement between ED and ES criteria. The kappa
statistic was used to compare ED and ES NC
measures (Table 5). The kappa statistic was 0.43,
which is only fair to moderate agreement. Both
measures categorized participants in the same group
77% of the time.
Interobserver and intraobserver agreement. The
interobserver agreement on ED compacted and
noncompacted layer thickness by Spearman’s cor-
relation was 0.8 and 0.81, respectively. The inter-
observer agreement for the ES compacted and
noncompacted layer measures was 0.82 and 0.78,
respectively. The interobserver agreement for
TMTMR was 0.85, and the interobserver agree-
ment for papillary muscle classiﬁcation had a kappa
statistic of 0.82, which is good agreement (>90%
classiﬁed in the same group). The intraobserver
agreement on ED compacted and noncompacted
layer thickness by Spearman’s correlation was 0.82
and 0.84, respectively. The intraobserver agreement
for the ES compacted and noncompacted layer
measurements was 0.84 and 0.83, respectively. The
intraobserver agreement for TMTMR was 0.87,
and the intraobserver agreement for papillary muscle
classiﬁcation had a kappa statistic of 0.8, which is
good agreement.DISCUSS ION
This study highlights the difference in information
provided by the noncompacted-to-compacted ratio
measured at end-systole versus end-diastole using
Table 4. Percentage of Each Papillary Muscle Group Present in Those Who Fulﬁlled and Did Not Fulﬁll Different Criteria for
Noncompaction
Association Between Papillary Muscle Groups and Different Measures of Noncompaction
Papillary Muscle Group
ES NC:C
Ratio <2
ES NC:C
Ratio ‡2
ED NC:C
Ratio <2.3
ED NC:C
Ratio ‡2.3
TrabM:TM
Ratio <40%
TrabM:TM
Ratio ‡40%
0 (%) 37.5 62.5 46.9 53.1 31.3 68.7
1 (%) 84.2 16.8 52.6 47.4 33.3 66.7
2 (%) 88.7 11.3 88.7 11.3 50 50
By chi-square analysis, both the ES NC:C ratio and ED NC:C ratio had a p value <0.001, but the TrabM:TM ratio had a p value of 0.017.
Abbreviations as in Table 2.
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938CMR as well as the TMTMR. Four important ob-
servations are supported by the data. First, end-systole
data generated by CMR LVNC are attainable in
an unselected population of patients who underwent
cardiac evaluation for various etiologies. Second,
CMR measures of LVNC using the ESNCCR
compared with the EDNCCR and the TMTMR
criteria had stronger associations with LVEF and
MT, imaging variables associated with cardiac
dysfunction. Both ESNCCR and EDNCCR were
associated with LVEDVi, a marker of ventricular
remodeling, but only ESNCCR was associated with
a greater sphericity index. Third, CMR ESNCCR
criteria used to identify LVNC have the greatest
OR (OR: 29.4) for clinical heart failure and those
clinical events (OR: 8.6) classically associated with
LVNC cardiomyopathy (heart failure readmissions,
ventricular arrhythmias, embolic events). Fourth,
different criteria were associated with abnormal
papillary muscle structure, which may indicate
abnormal development. Thus, we advocate adopting
the ESNCCR criteria presented as the CMR
phenotype for LVNC cardiomyopathy.
The most rigorously tested criteria for diagnosing
NC cardiomyopathy was proposed by Jenni et al.
using echocardiography (2,8). They proposed 4
imaging criteria to establish the diagnosis: 1) the
myocardial wall has to be thickened with a 2-layered
structure and an ESNCCR >2 from the parasternalTable 5. Frequency Table: Kappa Agreement Statistic
Was 0.43, Which Is Fair to Moderate Agreement
Comparison of Agreement Between ES and ED Measures
of Noncompaction
Measure
ED NC:C
Ratio <2.3
ED NC:C
Ratio ‡2.3 Total
ES NC:C ratio <2 76 15 91
ES NC:C ratio $2 12 19 31
Total 88 34 122
Assuming ES measures as standard, the ED measures’ positive predictive value
is 56%, and the negative predictive value is 86%.
Abbreviations as in Table 2.short-axis view; 2) the predominant location of the
pathology is apical, mid-lateral, and mid-inferior; 3)
the absence of coexisting cardiac abnormality; 4) the
demonstration of color Doppler ﬂow in the recesses
of the trabeculations. The original data included 38
patients, and subsequently the criteria were validated
using a second population of 18 patients. The ES
measures were found to be signiﬁcantly related to
ventricular arrhythmias (21), CHF (1,2), and
thromboembolic phenomenon (1,2). Our popula-
tion was not rigorously or prospectively evaluated for
the clinical phenotype associated with LVNC.
However, we did demonstrate signiﬁcant differences
in LVEF, MT, 3DSi, and clinical diagnosis of heart
failure, as well as a strong association of clinical
events classically associated with LVNC.
In the early 2000s, an effort was made to correlate
ES measures between echocardiography and CMR
(10). However, due to small sample size and less-
than-optimal CMR imaging sequences, the authors
were unable to demonstrate signiﬁcant correlations.
Subsequently, Petersen et al. (11) evaluated 6 patients
with LVNC and proposed CMR criteria of
EDNCCR >2.3. Fazio et al. (22) extended this
research and proposed CMR criteria of EDNCCR
>2.5. Following these publications, many centers
adopted ED measurements to deﬁne the imaging
criteria for LVNC.This trend has led some authors to
believe that LVNC is overdiagnosed as a phenotype,
which could carry signiﬁcant clinical implications (6).
Although ED cutoff points are commonly seen in
normal populations (4,23), the ES measurements of
the short axis are not (4). More recently, interest has
increased in theTMTMR tomore accurately identify
those with abnormal trabeculations (12).
Previous studies focused on a threshold point to
determine imaging criteria for LVNC either by
echocardiography orCMR.Our study demonstrates a
linear relationship between theESNCCRandLVEF,
LVEDVi, 3DSi, and MT. ES measures may also
provide intrinsic information about the underlying
function of the compactedmyocardium as assessed by
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 9 , 2 0 1 3 Stacey et al.
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939MT (24–29). We demonstrated a strong statistically
signiﬁcant correlation between greater ESNCCR and
worse MT (Fig. 3). Our data suggest that even after
adjustment for covariates, the ESNCCR criteria had
the greatest OR (OR: 29.4) for identifying a clinical
diagnosis of heart failure. Although we cannot
conclude that the diagnosis of heart failure equates to
the clinical phenotype of LVNC cardiomyopathy, it
stands to reason that in the absence of other cardiac
disorders, the presence of both a depressed LVEF and
NC may be related, especially because the prevalence
of those meeting the ESNCCR criteria in this study
was 0.6% in our CMR database, comparable to other
reported frequencies (30,31).
Our study supports that ED measurements have
weaker associations with LV function, but may
provide additional information. The median LVEF
of those who met ED criteria but not ES criteria
was 52%. This means that almost half of those who
met ED criteria had essentially normal LV systolic
function. Morphologically, both ES and ED mea-
surements had abnormal papillary muscle structure.
As such, ED measurements may identify individuals
who are at higher risk of the development of sub-
sequent LV dysfunction. Interestingly, those who
met the TMTMR criteria were at slightly increased
odds of having clinical events historically associated
with NC, which suggests that it may have a more
emerging role.
Study limitations. There are several limitations
inherent in any retrospective database analysis. First,
with this being a retrospective analysis, our results are
hypothesis generating. Our ﬁndings will need to be
validated by a more prospective approach, which may
be difﬁcult given the rare nature of LVNC. Other
relevant limitations to our investigation include
referral bias, lack of a previous echocardiogram to
establish diagnosis, incomplete clinical variables, and
variations in how trabecular mass was assessed. First,we are a large tertiary care referral center for CMR
and, as such, may have a greater representation of rare
cardiovascular disorders including LVNC. Second,
in most situations, participants had nondiagnostic
echocardiograms or were referred from an outside
institution without available echocardiograms.
Third, the reliance of clinical records to establish
diagnoses can result in misclassiﬁcation, but in many
instances, we lacked the necessary records to appro-
priately classify individuals and therefore had to rely
on documentation for many of the diagnoses.
Fourth, it may be difﬁcult to compare our TMTMRs
with those previously published due to a different
cutoff. Our concern was that we could not reliably
separate trabeculations from papillary muscles, which
could introduce a signiﬁcant amount of bias to our
study. Therefore, we elected to measure them
together and use previous literature to help us have a
higher cutoff. Finally, LVNC appears to be a clinical
syndrome characterized with signiﬁcant variation in
presentation.CONCLUS IONS
ES NC-to-compaction ratios $2 are feasible by
CMR, have the strongest relationship with LV
function, and have the strongest OR for identifying
clinical heart failure and clinical events. Future
studies in either established LV noncompaction
clinical phenotypes or longitudinal investigations of
imaging criteria are needed to conﬁrm the clinical
signiﬁcance of these ﬁndings.Reprint requests and correspondence: Dr. R. Brandon
Stacey, Cardiology Section, Watlington Hall, Wake
Forest University School of Medicine, Medical Center
Boulevard, Winston-Salem, North Carolina 27157-1045.
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